Senti Biosciences (SNTI) Current Assets (2021 - 2025)

Senti Biosciences has reported Current Assets for 5 years, with the latest figure at $23.3 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 60.53% year-over-year to $23.3 million; the trailing twelve-month figure through Dec 2025 stood at $23.3 million (down 60.53% YoY), and the FY2025 full-year result was $23.3 million, down 60.53% from the prior year.
• Current Assets for Q4 2025 stood at $23.3 million, up from $18.2 million in the prior quarter.
• The five-year high for Current Assets was $143.9 million in Q2 2022, with the low at $827152.0 in Q1 2022.
• Average Current Assets over 5 years is $53.7 million, with a median of $55.7 million recorded in 2024.
• Year-over-year, Current Assets soared 9633.52% in 2023 and plunged 78.0% in 2024.
• Tracing SNTI's Current Assets over 5 years: stood at $60.2 million in 2021, then surged by 70.42% to $102.6 million in 2022, then plunged by 30.59% to $71.2 million in 2023, then slipped by 17.19% to $59.0 million in 2024, then sank by 60.53% to $23.3 million in 2025.
• The last three Current Assets figures came in at $23.3 million (Q4 2025), $18.2 million (Q3 2025), and $32.5 million (Q2 2025), per Business Quant data.

Peer Comparison